| Literature DB >> 35049939 |
Akash Sivam1, Natalie Enninghorst2,3.
Abstract
The aim of this study is to present a narrative review of the properties of materials currently used for orbital floor reconstruction. Orbital floor fractures, due to their complex anatomy, physiology, and aesthetic concerns, pose complexities regarding management. Since the 1950s, a myriad of materials has been used to reconstruct orbital floor fractures. This narrative review synthesises the findings of literature retrieved from search of PubMed, Web of Science, and Google Scholar databases. This narrative review was conducted of 66 studies on reconstructive materials. Ideal material properties are that they are resorbable, osteoconductive, resistant to infection, minimally reactive, do not induce capsule formation, allow for bony ingrowth, are cheap, and readily available. Autologous implants provide reliable, lifelong, and biocompatible material choices. Allogenic materials pose a threat of catastrophic disease transmission. Newer alloplastic materials have gained popularity. Consideration must be made when deliberating the use of permanent alloplastic materials that are a foreign body with potential body interactions, or the use of resorbable alloplastic materials failing to provide adequate support for orbital contents. It is vital that surgeons have an appropriate knowledge of materials so that they are used appropriately and reduce the risks of complications.Entities:
Keywords: biomaterials; complications; orbit; orbital fracture; orbital implants; orbital reconstruction
Year: 2022 PMID: 35049939 PMCID: PMC8778999 DOI: 10.3390/medicines9010006
Source DB: PubMed Journal: Medicines (Basel) ISSN: 2305-6320
Figure 1PRISMA flowchart of study selection.
American Society of Plastic Surgeons Level of Evidence Rating Scale for Therapeutic Studies.
| Level of | Qualifying Studies |
|---|---|
| I | High-quality, multi-centered or single-centered, randomized controlled trial with adequate power; or systematic review of these studies |
| II | Lesser-quality, randomized controlled trial; prospective cohort or comparative study; or systematic review of these studies |
| III | Retrospective cohort or comparative study; case-control study; or systematic review of these studies |
| IV | Case series with pre/post test; or only post test |
| V | Expert opinion developed via consensus process; case report or clinical example; or evidence based on physiology, bench research or “first principles” |
List of retrieved studies reported on implant material and postoperative complications.
| Author | Level of Study | Type of Study | Implant Materials | Follow-Up |
|---|---|---|---|---|
| Aitasalo et al. [ | III | Retrospective review | Bioactive glass | 1 to 12 months |
| Al-Sukhun and | III | Comparative study | Autogenous bone grafts, poly-L/DL-Lactide [P(L/DL)LA 70/30] | 2–36 weeks |
| Al-Sukhun et al. [ | III | Retrospective cohort study | Poly-L/DL-Lactide [P(L/DL)LA 70/30] | - |
| Aronowitz et al. [ | III | Retrospective study | Teflon (PTFE) | Mean, 16 years |
| Asamura et al. [ | III | Retrospective cohort study | Ilium and periosteum polymer complex | 2–22 months |
| Balogh et al. [ | III | Retrospective cohort study | Polyglycolic acid (PGA) | 24 to 43 months |
| Baumann et al. [ | III | Follow-up study | Polydioxanone | 6 months |
| Brucoli et al. [ | III | Retrospective cohort study | Autologous calvarial bone, titanium mesh, tutopatch sheet | Mean, 39 months |
| Constantian [ | IV | Case series | Autogenous tissues | 7 months to 3.5 years |
| Cordewener et al. [ | III | Retrospective cohort study | Poly-D-Lactic Acid | - |
| Düzgün and Sirkeci [ | III | Comparative study | Cartilage, bone grafts, titanium mesh, porous polyethylene implant | Mean, 14 months |
| Ellis and Tan [ | III | Retrospective review | Cranial bone grafts, titanium mesh | - |
| Guerra et al. [ | III | Retrospective study | Allogenic lyophilized dura | 3 months to 1 year |
| Guo et al. [ | III | Comparative study | Calvaria bone graft, titanium mesh | >2 weeks |
| Hollier et al. [ | III | Retrospective cohort study | Polyglycolic Acid (PGA) | Upto 12 months |
| Holtmann et al. [ | III | Retrospective study | Titanium mesh | - |
| Hwang and Kita [ | III | Prospective study | Titanium mesh | - |
| Iizuka et al. [ | III | Prospective study | Polydioxanone | 9 to 45 months |
| Kinnunen et al. [ | III | Comparative study | Autogenous ear cartilage, bioactive glass | 2 to 5 years |
| Kirby et al. [ | III | Retrospective cohort study | Autologous bone, Titanium, porous polyethylene | Mean, 38.8 weeks |
| Klisovic et al. [ | IV | Case report | Silicone | 18 months |
| Kontio et al. [ | III | Prospective study | Polydioxanone | Mean, 29 weeks |
| Kontio et al. [ | III | Prospective study | Iliac bone graft | Mean, 7.8 months |
| Kraus et al. [ | III | Prospective study | Autogenous septal cartilage | 1 week to 6 months |
| Lai, A. [ | III | Prospective study | Nasal septal cartilage | 3 months to 4 years |
| Lee and Nunery [ | III | Retrospective review | Titanium mesh and titanium plate | 5 to 18 months |
| Lieger et al. [ | III | Retrospective study | Poly-L/DL-Lactide [P(L/DL)LA 70/30] | 3 to 12 months |
| Lipshutz and Ardizone [ | IV | Case series | Silicone | - |
| Lupi et al. [ | III | Retrospective study | Porous polyethylene | - |
| Mauriello et al. [ | III | Case series | Polyglactin | 1 to 24 months |
| Polley and Ringler [ | III | Retrospective study | Teflon (PTFE) | 3 months to 15 years |
| Romano et al. [ | III | Prospective study | Porous polyethylene | - |
| Rubin and Yaremchuk [ | III | Comprehensive review | Porous polyethylene, dense polyethylene, silicone, tefflon (PTFE) | - |
| Sewall et al. [ | IV | Case report | Silicone | - |
| Sugar et al. [ | III | Prospective study | Titanium mesh | Mean, 24 months |
| Waite and Clanton [ | III | Prospective study | Lyophilized dura | 12 months |
| Wang et al. [ | III | Retrospective study | Autogenous bone, titanium mesh, Medpor | 1 to 6 months |
| Young et al. [ | III | Retrospective review | Poly-L/DL-lactide (P[L/DL]LA) 85/15, (P[L/DL]LA) 70/30, Polycaprolactone | 15 to 24 months |
| Zunz et al. [ | IV | Case series | Calvarial, iliac autogenous bone grafts | Mean, 12.5 months |
- Not reported.
Reconstruction materials and postoperative complications.
| Implant Material | Author | Patients | Complications | Total |
|---|---|---|---|---|
| Autologous Calvarial Bone | Brucoli et al. [ | 87 | Diplopia (7) | 17 |
| Autologous Iliac Bone | Düzgün and Sirkeci [ | 72 | Diplopia (15) | 30 |
| Autologous Bone (unspecified donor site) | Kirby et al. [ | 71 | Re-operation (17) | 57 |
| Autologous Conchal Ear Cartilage | Constantian [ | 33 | Diplopia (8) | 12 |
| Autologous Nasal Septal Cartilage | Kraus et al. [ | 33 | Enophthalmos (1) | 4 |
| Allogenic Lyophilized Dura | Waite and Clanton [ | 70 | Enophthalmos (3) | 9 |
| Titanium | Brucoli et al. [ | 741 | Re-operation (16) | 80 |
| Porous Polyethylene | Kirby et al. [ | 326 | Re-operation (23) | 73 |
| Dense Polyethylene | Rubin and Yaremchuk [ | 78 | Removal (1) | 6 |
| Bioactive Glass | Kinnunen et al. [ | 50 | Diplopia (5) | 13 |
| Silicone | Rubin and Yaremchuk [ | 530 | Infection (25) | 93 |
| Teflon (PTFE) | Rubin and Yaremchuk [ | 702 | Diplopia (11) | 43 |
| Polyglycolic Acid (PGA) | Balogh et al. [ | 78 | Enophthalmos (2) | 4 |
| Polyglactin | Mauriello et al. [ | 28 | Inflammation (4) | 4 |
| Polydioxanone | Holtman et al. [ | 774 | Diplopia (38) | 78 |
| Poly-D-Lactic Acid | Cordewener et al. [ | 176 | Diplopia (1) | 6 |
| Unspecified Implants | Wang et al. [ | 21 | Diplopia (1) | 5 |
Postoperative complications attributed to implant material.
| Implant Material | Total Number of Patients | Complications Rates (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Exposure/Extrusion | Fistula | Infection | Inflammation | Pain | Persistent/Prolonged Oedema | Prominence | Removal of Implant | Overall | ||
| Autologous Calvarial Bone | 87 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Autologous Iliac Bone | 72 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Autologous Bone (unspecified donor site) | 71 | 0 | 0 | 5.6 | 0 | 0 | 0 | 0 | 5.6 | 11.3 |
| Autologous Conchal Ear Cartilage | 33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Autologous Nasal Septal Cartilage | 33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Allogenic Lyophilized Dura | 70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Titanium | 741 | 0 | 0 | 1.1 | 0 | 0 | 0 | 0 | 1.3 | 2.4 |
| Porous Polyethylene | 326 | 0.7 | 0 | 2.3 | 0 | 0 | 0 | 0 | 2.3 | 5.4 |
| Dense Polyethylene | 78 | 0 | 0 | 2.6 | 0 | 0 | 3.8 | 0 | 1.3 | 7.7 |
| Bioactive Glass | 50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.0 | 2.0 |
| Silicone | 530 | 3.0 | 0 | 4.7 | 0 | 1.1 | 0.4 | 0.4 | 7.9 | 17.5 |
| Teflon (PTFE) | 702 | 0.6 | 0.1 | 0.4 | 0 | 0 | 0 | 0 | 1.3 | 2.4 |
| Polyglycolic Acid (PGA) | 78 | 0 | 0 | 0 | 1.3 | 0 | 0 | 0 | 0 | 1.3 |
| Polyglactin | 28 | 0 | 0 | 0 | 14.3 | 0 | 0 | 0 | 0 | 14.3 |
| Polydioxanone | 774 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0 | 0.1 |
| Poly-D-Lactic Acid | 176 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Unspecified Implants | 21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |